Europe — EMA

Novolizer (Budesonide)

Request sourcing

Pack/s

What is Budesonide?

Budesonide, the active ingredient in Novolizer, is a glucocorticoid presented as a inhalation powder for respiratory use. It treats asthma and chronic obstructive pulmonary disease (COPD) in adults and adolescents. GNH USA supplies Novolizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novolizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Budesonide used for?

Novolizer is a glucocorticoid that acts on airway inflammation in respiratory disease.

- Asthma: improves lung function and reduces the frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): lowers the ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - … - … - …. - … - …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →